Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCAD.

[1]  S. Fesik,et al.  MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. , 2017, Cell metabolism.

[2]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[3]  A. Strasser,et al.  The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.

[4]  H. Land,et al.  Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells , 2016, Cell reports.

[5]  S. Gygi,et al.  PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2. , 2016, Molecular cell.

[6]  John M Denu,et al.  Mechanisms and Dynamics of Protein Acetylation in Mitochondria. , 2016, Trends in biochemical sciences.

[7]  G C P van Zundert,et al.  The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.

[8]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[9]  M. Wajner,et al.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies , 2015, Bioscience reports.

[10]  P. Tompa,et al.  Redefining the BH3 Death Domain as a ‘Short Linear Motif’ , 2015, Trends in Biochemical Sciences.

[11]  Damian Szklarczyk,et al.  Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell‐lines , 2015, Proteomics.

[12]  L. Walensky,et al.  Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. , 2015, Molecular cell.

[13]  G. Superti-Furga,et al.  SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.

[14]  L. Walensky,et al.  Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress , 2014, Journal of medicinal chemistry.

[15]  Y. Huang,et al.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance. , 2014, American journal of physiology. Heart and circulatory physiology.

[16]  Amber L. Couzens,et al.  The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.

[17]  J. Opferman,et al.  Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. , 2013, Genes & development.

[18]  L. Lam,et al.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.

[19]  Michael R. Green,et al.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. , 2012, Cancer cell.

[20]  Jennifer L Greene,et al.  Nitric Oxide Regulates Mitochondrial Fatty Acid Metabolism Through Reversible Protein S-Nitrosylation , 2013, Science Signaling.

[21]  Daniel P. Stewart,et al.  Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration , 2012, Nature Cell Biology.

[22]  L. Walensky,et al.  BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. , 2011, Trends in biochemical sciences.

[23]  David C Muddiman,et al.  Evaluation of Normalization Methods on GeLC-MS/MS Label-Free Spectral Counting Data to Correct for Variation during Proteomic Workflows , 2011, Journal of the American Society for Mass Spectrometry.

[24]  L. Walensky,et al.  Chemical Synthesis of Hydrocarbon‐Stapled Peptides for Protein Interaction Research and Therapeutic Targeting , 2011, Current protocols in chemical biology.

[25]  S. Gygi,et al.  Photoreactive stapled BH3 peptides to dissect the BCL-2 family interactome. , 2010, Chemistry & biology.

[26]  Emiko Fire,et al.  The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer , 2010, Nature chemical biology.

[27]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[28]  K. Kaluarachchi,et al.  Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. , 2010, The Journal of clinical investigation.

[29]  John R. Engen,et al.  Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. , 2009, Analytical chemistry.

[30]  Bas J. Wouters,et al.  Brief Report Results and Discussion , 2022 .

[31]  R. Wanders,et al.  Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation. , 2008, Molecular genetics and metabolism.

[32]  S. R. Datta,et al.  Dual role of proapoptotic BAD in insulin secretion and beta cell survival , 2008, Nature Medicine.

[33]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[34]  Yudong Wang,et al.  Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic system. , 2007, Molecular genetics and metabolism.

[35]  R. Youle,et al.  Role of Bax and Bak in mitochondrial morphogenesis , 2006, Nature.

[36]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[37]  Yan Wu,et al.  Extensive deuterium back-exchange in certain immobilized pepsin columns used for H/D exchange mass spectrometry. , 2006, Analytical chemistry.

[38]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Lerenthal,et al.  Proapoptotic BID Is an ATM Effector in the DNA-Damage Response , 2005, Cell.

[40]  S. Korsmeyer,et al.  A Role for Proapoptotic BID in the DNA-Damage Response , 2005, Cell.

[41]  S. Korsmeyer,et al.  Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells , 2005, Science.

[42]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[43]  S. Korsmeyer,et al.  Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From , 2022 .

[44]  S. Korsmeyer,et al.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 , 2003, Nature.

[45]  S. R. Datta,et al.  BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis , 2003, Nature.

[46]  M. Hofker.  Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. , 2003 .

[47]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[48]  D. Millington,et al.  Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders , 2000, Journal of Inherited Metabolic Disease.

[49]  K. Roth,et al.  Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.

[50]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[51]  D. Hale,et al.  Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Hale,et al.  An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.

[53]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[54]  A. P. Diz,et al.  Multiple hypothesis testing in proteomics: A strategy for experimental work. , 2010, Molecular & cellular proteomics : MCP.

[55]  J. Gray,et al.  Enhancing transduction of the liver by adeno-associated viral vectors , 2009, Gene Therapy.

[56]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[57]  T. Wales,et al.  Hydrogen exchange mass spectrometry for the analysis of protein dynamics. , 2006, Mass spectrometry reviews.